2500 — Venus MedTech HangZhou Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -300 | -382 | -186 | -378 | -1,156 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 240 | 128 | 23.9 | -4.13 | 439 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -102 | -78.5 | -113 | -127 | -125 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -151 | -303 | -237 | -457 | -729 |
Capital Expenditures | -26.5 | -24.5 | -124 | -145 | -179 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -168 | -6.44 | -174 | -508 | -893 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -194 | -31 | -298 | -653 | -1,072 |
Financing Cash Flow Items | 436 | -133 | -251 | 45.3 | -66.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 453 | 2,577 | 928 | 1,391 | 635 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 106 | 2,248 | 295 | 247 | -1,076 |